PDL1 and CD38 antigen expression in NSCLC
views
Torben Plesner, MD, from the Vejle Hospital and University of Southern Denmark, Vejle, Denmark, discusses antigen expression …
From: admin
Category: Uncategorized
Tags: antigen, CD38, checkpoint inhibitors, chemotherapy, Event: COMy 2017, Field: Immuno-Oncology, Format: Interview, lung cancer, Medicines: Checkpoint Inhibitors, Medicines: Daratumumab, non-small cell lung cancer, NSCLC, PDL1, Resistance, Response, Speaker: Torben Plesner, Subject: Multiple Myeloma, therapy, treatment
Added on: septiembre 21, 2022
